|
| | | | |
| | | |
| Stat |
Members: 3645
Articles: 2'504'928
Articles rated: 2609
25 April 2024 |
|
| | | | |
|
Article overview
| |
|
|
Cold-atmospheric plasma induces tumor cell death in preclinical in vivo and in vitro models of human cholangiocarcinoma | | Javier Vaquero
; Florian Judée
; Marie Vallette
; Henri Decauchy
; Ander Arbelaiz
; Lynda Aoudjehane
; Olivier Scatton
; Ester Gonzalez-Sanchez
; Fatiha Merabtene
; Jérémy Augustin
; Chantal Housset
; Thierry Dufour
; Laura Fouassier
; | | Date: |
27 Jul 2020 | | Abstract: | Through the last decade, cold atmospheric plasma (CAP) has emerged as an
innovative therapeutic option for cancer treatment. Recently, we have set up a
potentially safe atmospheric pressure plasma jet device that displays
antitumoral properties in a preclinical model of cholangiocarcinoma (CCA), a
rare and very aggressive cancer emerging from the biliary tree with few
efficient treatments. In the present study, we aimed at deciphering the
molecular mechanisms underlying the antitumor effects of CAP towards CCA both
in an in vivo and in vitro context. In vivo, using subcutaneous xenografts into
immunocompromised mice, CAP treatment of CCA induced DNA lesions and tumor cell
apoptosis, as evaluated by 8-oxoguanine and cleaved caspase-3
immunohistochemistry, respectively. Analysis of the tumor microenvironment
showed changes in markers related to macrophage polarization. In vitro,
incubation of CCA cells with CAP-treated culture media (i.e. plasma-activated
media, PAM) led to a dose response decrease in cell survival. At molecular
level, CAP treatment induced double-strand DNA breaks, followed by an increased
phosphorylation and activation of the cell cycle master regulators CHK1 and
p53, leading to cell cycle arrest and cell death by apoptosis. In conclusion,
CAP is a novel therapeutic option to consider for CCA in the future. | | Source: | arXiv, 2007.15093 | | Services: | Forum | Review | PDF | Favorites | |
|
|
No review found.
Did you like this article?
Note: answers to reviews or questions about the article must be posted in the forum section.
Authors are not allowed to review their own article. They can use the forum section.
browser Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)
|
| |
|
|
|
|
News, job offers and information for researchers and scientists:
| |
REGISTER